ATLANTA — Maternal vaccination and immunization with nirsevimab both produce strong increases in infant neutralizing antibody levels against respiratory syncytial virus, according to phase 4 data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback